找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Combination Treatment in Autoimmune Diseases; W. B. Harrison,B. A. C. Dijkmans Book 2002 Springer-Verlag Berlin Heidelberg 2002 Autoimmune

[復(fù)制鏈接]
樓主: FETUS
11#
發(fā)表于 2025-3-23 11:03:05 | 只看該作者
12#
發(fā)表于 2025-3-23 17:49:51 | 只看該作者
Spondylarthropathies: options for combination therapy of diseases. Patients may have more than one symptom at the same time or at different moments during life. A positive family history is an important hallmark of SpA, and reflects its genetic background.
13#
發(fā)表于 2025-3-23 20:24:15 | 只看該作者
Christoph G. Schuetz,Michael Schreflale population (6% overall), and an annual prevalence of SSc of 15 cases per 100,000. Data from the UK has previously estimated a much lower prevalence but a comprehensive local study has led to estimates being revised to levels similar to the North American figures [28].
14#
發(fā)表于 2025-3-24 01:20:03 | 只看該作者
Combination therapies for systemic sclerosisale population (6% overall), and an annual prevalence of SSc of 15 cases per 100,000. Data from the UK has previously estimated a much lower prevalence but a comprehensive local study has led to estimates being revised to levels similar to the North American figures [28].
15#
發(fā)表于 2025-3-24 03:08:57 | 只看該作者
16#
發(fā)表于 2025-3-24 08:56:21 | 只看該作者
A Survey of IoT Software Platformsggressive initial therapy. These adagia have influenced in recent times all fields of medicine, from oncology to infectious diseases and also — the topic of the present edition — the “autoimmune diseases”. As an example of the latter, rheumatoid arthritis (RA) demonstrates how the attitude of physicians has been changed.
17#
發(fā)表于 2025-3-24 13:18:46 | 只看該作者
https://doi.org/10.1007/978-3-319-14139-8ture mortality. Even though methotrexate (MTX) has become a “gold standard” of therapy, its use rarely results in disease remission. The recent introduction of new treatments which offer significant incremental improvements in both efficacy and tolerability argues strongly for utilization of combination therapy.
18#
發(fā)表于 2025-3-24 17:15:21 | 只看該作者
19#
發(fā)表于 2025-3-24 22:32:34 | 只看該作者
20#
發(fā)表于 2025-3-25 00:16:28 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 22:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
青冈县| 兴义市| 澄迈县| 湖南省| 九龙城区| 萍乡市| 房山区| 息烽县| 北流市| 泰顺县| 泗洪县| 孟津县| 乃东县| 遵义县| 西吉县| 东山县| 察哈| 博罗县| 连城县| 拜泉县| 临江市| 浦县| 灯塔市| 吉木乃县| 于田县| 饶河县| 金川县| 涿鹿县| 宣威市| 环江| 绥中县| 济源市| 同江市| 武安市| 巴南区| 固阳县| 常德市| 汉寿县| 会昌县| 吴川市| 昂仁县|